Flag of the European Union EU Clinical Trials Register Help

Clinical trials for $1

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

  • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).


    The EU Clinical Trials Register currently displays   43861   clinical trials with a EudraCT protocol, of which   7284   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    38,831 result(s) found for: $1. Displaying page 1,491 of 1,942.
    EudraCT Number: 2004-003853-13 Sponsor Protocol Number: HPEPA-01 Start Date*: 2005-01-13
    Sponsor Name:Hela Pharma AB
    Full Title: Placebo controlled, randomised, double-blind, multicentre study of PlusEPA (a PUFA, Polyunsaturated Fatty Acids, supplement) as treatment for ADHD (combined type) with co-morbidity in Swedish child...
    Medical condition: ADHD (combined type) and co-morbidity in children
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-002887-41 Sponsor Protocol Number: OV-W05 Start Date*: 2004-12-01
    Sponsor Name:OmniVision GmbH
    Full Title: Randomisierte, kontrollierte, für den Prüfer verblindete klinische Prüfung (Pilotstudie) zur Untersuchung der Wirksamkeit von Spersadex® Augentropfen im Vergleich zu Isopto®-Dex Augentropfen bei Pa...
    Medical condition: Nicht-infektiöse Conjunctivitis
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2004-005020-41 Sponsor Protocol Number: AMG 001 Start Date*: 2005-06-06
    Sponsor Name:Heinrich Heine Universität Düsseldorf
    Full Title: Topische Anwendung von Tacrolimus (Protopic) bei verschiedenen Formen des kutanen Lupus erythe-matodes im Rahmen einer klinischen Untersuchung an mehreren nationalen Zentren
    Medical condition: kutaner Lupus erythematodes Die Patienten zeigen meist an der Haut erythematöse Plaques im Rahmen dieser Erkrankung, welche häufig im Gesicht auftreten, schmerzempfindlich sind und zentral vernarb...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-003740-22 Sponsor Protocol Number: A25/04-ZKSD Start Date*: 2005-04-08
    Sponsor Name:PKH-Pharmazeutische Kontroll- und Herstellungslabor GmbH
    Full Title: Doppelblinder, randomisierter, vehikel- und referenzkontrollierter Nachweis der antibakteriellen Wirksamkeit von Kaliumpermanganat(0,001%)-enthaltenden topischen Präparationen zur epikutanen Applik...
    Medical condition: Objective of the trial is the testing of the antibacterial efficacy of a Kaliumpermanaganat (0.001%)-containing topical preparation for cutaneous application in healthy volunteers
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-000558-60 Sponsor Protocol Number: PX104.1.7-202 Start Date*: 2005-06-02
    Sponsor Name:Pharmexa A/S
    Full Title: A Phase II trial evaluating the immunological and clinical efficacy and safety of HER-2 Protein AutoVac(TM) and Stimulon® Adjuvant QS-21 monotherapy in patients with metastatic breast cancer
    Medical condition: Female patients with histologically proven metastatic or locally advanced breast cancer who have HER-2 overexpression in the primary tumour and/or a metastatic lesion.
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: HU (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-002110-38 Sponsor Protocol Number: 20050506 Start Date*: 2007-09-12
    Sponsor Name:Dept of ped hem/onc
    Full Title: RCT of oral paracetamol for procedural anxiety, distress and pain in children with cancer
    Medical condition: Pain relif before needle insertion in a subcoutanously implanted iv port in children with cancer
    Disease:
    Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2005-001363-58 Sponsor Protocol Number: PPAPR0202 Start Date*: 2006-11-14
    Sponsor Name:Photopharmica Ltd
    Full Title: Phase IIa randomised, placebo controlled trial to investiagte antimicrobial photodynamic therapy in chronic leg ulcers and diabetic foot ulcers.
    Medical condition: Chronic leg ulcers and chronic diabetic foot ulcers
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-004822-29 Sponsor Protocol Number: CHL1/02-2004 Start Date*: 2005-03-09
    Sponsor Name:SINTETICA SA
    Full Title: Spinal anaesthesia with 2 -chlopoprocaine 1% for lower limb procedures of short duration: a prospective randomized, blind, dose-finding study.
    Medical condition: Spinal anaesthesia for short therm surgical procedures
    Disease: Version SOC Term Classification Code Term Level
    6.1 10041536 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-002850-69 Sponsor Protocol Number: IGPM01 Start Date*: 2006-01-06
    Sponsor Name:Swansea NHS Trust
    Full Title: Role of High dose insulin and glucose-potassium-magnesium (HDI-GKM) for Myocardial protection in cardiac surgery
    Medical condition: We propose to recruit 90 patients (based on the power calculation) undergoing first time urgent in-house CABG at Morriston Hospital. The decision to operate on an urgent basis will be based on the ...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2005-001700-39 Sponsor Protocol Number: IP-REM-PK-01-EU Start Date*: 2005-09-14
    Sponsor Name:Fresenius Biotech GmbH
    Full Title: Determination of systemic exposure and characterization of pharmacokinetics of the tri-functional antibody catumaxomab (anti-EpCAM X anti-CD3) administered intraperitoneally in EpCAM positive cance...
    Medical condition: epithelial cell adhesion molecule (EpCAM) expressing tumors in patients with malignant ascites requiring therapeutic ascites puncture
    Disease: Version SOC Term Classification Code Term Level
    9.1 10025538 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-005222-41 Sponsor Protocol Number: 04/Q2803/72 Start Date*: 2005-08-26
    Sponsor Name:UHCW NHS Trust
    Full Title: Intrathecal Morphine for pain management in patients undergoing major abdominal surgery: The optimal dose?
    Medical condition: The use of intrathecal morphine for post-operative pain relief following major abdominal surgery - the comparison of two doses (10 micrograms/kg and 20 micrograms/kg) medical condition = post-oper...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2004-005046-12 Sponsor Protocol Number: Final protocol Start Date*: 2005-09-22
    Sponsor Name:Ulster Community & Hospitals Trust
    Full Title: A double blind prospective randomised controlled trial to evaluate the effect of topical phenytoin on the healing of venous leg ulcers
    Medical condition: Venous Leg Ulceration
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2005-002832-93 Sponsor Protocol Number: TaxAlim01 Start Date*: 2006-11-16
    Sponsor Name:Städt. Krankenhaus Martha Maria Halle
    Full Title: Phase I/II-Studie Kombinationschemotherapie mit Docetaxel und Pemetrexed in der 2nd line-Therapie bei Patienten mit NSCLC, Stadium IIIB und IV
    Medical condition: Nichtkleinzelliges Bronchialkarzinom, Stadium IIIB und IV
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-003806-27 Sponsor Protocol Number: None avaliable Start Date*: 2005-10-13
    Sponsor Name:Princess Alexandra Hospital
    Full Title: Is potent topical corticosteroid ointment covered by a plastic film dressing more effective than using potent corticosteroid ointment alone in children with atopic dermatitis?
    Medical condition: Children aged 1-15 years with Atopic Dermatitis
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2005-005469-12 Sponsor Protocol Number: NEO-012 Start Date*: 2006-01-06
    Sponsor Name:Neolab Limited
    Full Title: A Phase III, randomised, double-blind, double-dummy cross-over study to compare two dry powder inhaled formulations of budesonide on methacholine hyper-reactivity in patients with stable, persisten...
    Medical condition: Stable, persistent, moderate asthma
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-005263-29 Sponsor Protocol Number: 25-01 Start Date*: 2006-01-31
    Sponsor Name:Gesellschaft fuer klinische Forschung e.V. (Society for Clinical Research) [...]
    1. Gesellschaft fuer klinische Forschung e.V. (Society for Clinical Research)
    2. WELEDA AG
    Full Title: Multiple Sclerosis and Extract of Cannabis (MUSEC): A randomised, double-blind, placebo-controlled phase III trial to determine the efficacy and safety of a standardised oral extract of Cannabis sa...
    Medical condition: Multiple Sclerosis
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-001696-19 Sponsor Protocol Number: TTD 04-01 Start Date*: 2005-01-26
    Sponsor Name:Spanish Cooperative Group for Gastrointestinal Tomour therapy
    Full Title: Open-label, phase II, multicentre study on cetuximab treatment as first-line monotherapy in elderly patients with metastatic colorectal cancer expressing EGFR
    Medical condition: Epidermal Growth Factor Receptor-expressing in metatstatic colorrectal cancer in first line treatment.
    Disease:
    Population Age: Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2006-001210-33 Sponsor Protocol Number: UHL 10054 Start Date*: 2006-06-20
    Sponsor Name:University Hospitals of Leicester NHS Trust
    Full Title: A cohort study of anticholinergic drugs in South Asian women with detrusor overactivity
    Medical condition: The medical condidtion is overactive bladder . A wide range of different anticholinergic agents is available to treat overactive bladder (OAB) symptoms. Within the last 15 years, ethno-pharmacologi...
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2005-000785-39 Sponsor Protocol Number: KETO 02/04 Start Date*: 2005-09-21
    Sponsor Name:MIPHARM
    Full Title: Efficacy and Tolerability of Ketomousse, Ketoconazole 1 , Salicilic Acid and Zinc phyritione thermolabile foam in the treatment of Pityriasis Versicolor in comparison with Ketoconazole 2 cream ...
    Medical condition: PITYRIASIS VERSICOLOR
    Disease: Version SOC Term Classification Code Term Level
    6.1 10056131 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-005645-19 Sponsor Protocol Number: 20051130 Start Date*: 2007-09-12
    Sponsor Name:Dept of ped hem/onc
    Full Title: RCT of oral ibuprofen for procedural anxiety, distress and pain in children with cancer
    Medical condition: Pain and anxiety relief before needle insertion in a subcutanously implanted iv port in children with cancer.
    Disease:
    Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri Apr 26 00:21:26 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA